Funding Opportunities


ARPA-H Precision Surgical Interventions
The PSI Broad Agency Announcement (BAA) calls for proposals focused on cancer localization, healthy structure localization, and improving outcomes during surgery. One portion of the BAA focuses on cancer surgeries, while another applies to surgeries for any relevant condition. Teams from different fields with knowledge of oncology, surgery, imaging technology, and other disciplines are invited to apply their expertise to the visualization needs of surgeons, in service of improved patient outcomes.

CTSC T32 Clinical and Translational Scientist Training Program for Postdoctoral Researchers
This program is now accepting applications for its first cohort of four postdocs, to begin in January 2024. Applications are due November 17, 2023. The Program aims to develop Clinical/Translational scientists with skills for interdisciplinary work, ability to work across disciplines, and ability to envision and design advances in clinical and community settings. We are seeking applications to fill four postdoctoral slots for the upcoming year. The appointment is for 2 years, January 2024 – December 31, 2025; second year is contingent upon satisfactory progress in the first of year support. 

CTSC Core Utilization Pilot Grants
The Clinical and Translational Science Collaborative (CTSC) of Case Western Reserve University Core Utilization Pilot Award Program supports investigator use of eligible Core facilities at our partner institutions. This program is designed to collect preliminary data that will lead to extramural sponsored grant funding and/or publications in peer-reviewed journals. Awards up to $10,000 are available. This program is intended to promote the use of technologies and expertise afforded by identified Core Facilities available at all partner institutions. Proposals are accepted on a rolling basis and must be submitted by 11:59 PM on the first day of every month (if the first falls on a weekend or holiday, the deadline is extended to the next working day).


ARPA-H makes pivotal investments in breakthrough technologies and broadly applicable platforms, capabilities, resources, and solutions with the potential to transform important areas of medicine and health that cannot readily be accomplished through traditional research or commercial activity. ARPA-H solutions aim to benefit everyone. Rolling submissions through March 14, 2024.